参考文献

2020-10-20

1: Zhang K, Zhang XQ, Lu W, Xie HR, He L, Jiang XH, Wang L. [Determination of Desloratadine and Its Metabolite 3-OH Desloratadine in Human Plasma by LC-MS/MS]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Sep;46(5):783-7, 804. Chinese. PubMed PMID: 26619557.

2: Ali AK. Torsade De Pointes And Qt Prolongation Could Result From Desloratadine Anti-Allergy Treatment. Value Health. 2015 Nov;18(7):A493-4. doi: 10.1016/j.jval.2015.09.1376. Epub 2015 Oct 20. PubMed PMID: 26532767.

3: Chen M, Xu S, Zhou P, He G, Jie Q, Wu Y. Desloratadine citrate disodium injection, a potent histamine H1 receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades. Eur J Pharmacol. 2015 Nov 15;767:98-107. doi: 10.1016/j.ejphar.2015.10.014. Epub 2015 Oct 9. PubMed PMID: 26455479.

4: Wang T, Zhang K, Li T, He L, Xie H, Jiang X, Wang L. Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers. Clin Drug Investig. 2015 Dec;35(12):807-13. doi: 10.1007/s40261-015-0343-1. PubMed PMID: 26446005.

5: Potter P, Mitha E, Barkai L, Gyorgyl M, Santamaria E, Izquierdo I, Maurer M. Rupatadine effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years: a randomized, double blind, placebo and desloratadine controlled study. Pediatr Allergy Immunol. 2015 Aug 12. doi: 10.1111/pai.12460. [Epub ahead of print] PubMed PMID: 26267219.

6: Tatar A, Parlak SN, Yayla M, Ugan RA, Polat E, Halici Z. Effects of allergic rhinitis and desloratadine on the submandibular gland in a rat allergy model. Int Forum Allergy Rhinol. 2015 Jul 22. doi: 10.1002/alr.21589. [Epub ahead of print] PubMed PMID: 26201305.

7: Yuan X, Ghosh A, Jie Q, He G, Wu Y. Effects of desloratadine citrate disodium injection on rat models of ovalbumin-induced allergic rhinitis: involvement of T-cell responses modulation. Int Forum Allergy Rhinol. 2015 Jul 8. doi: 10.1002/alr.21594. [Epub ahead of print] PubMed PMID: 26155922.

8: Kazmi F, Yerino P, Barbara JE, Parkinson A. Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor. Drug Metab Dispos. 2015 Sep;43(9):1294-302. doi: 10.1124/dmd.115.065011. Epub 2015 Jul 1. PubMed PMID: 26135009.

9: Jie Q, Kodithuwakku ND, Yuan X, He G, Chen M, Xu S, Wu Y. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells. Eur J Pharmacol. 2015 May 5;754:1-10. doi: 10.1016/j.ejphar.2015.02.016. Epub 2015 Feb 19. PubMed PMID: 25704613.

10: Kazmi F, Barbara JE, Yerino P, Parkinson A. A long-standing mystery solved: the formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirement. Drug Metab Dispos. 2015 Apr;43(4):523-33. doi: 10.1124/dmd.114.062620. Epub 2015 Jan 16. PubMed PMID: 25595597.